Search - tctmd.com

Displaying 1 - 20 of 49

Sort: Relevancy | Date

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

Todd Neale

September 30, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

Presentation TCT 2019

Case 3: A Patient With AF and ACS

Presenter: C. Michael Gibson

September 28, 2019

Presentation TCT 2019

Case 2: A Patient With Complex Disease Who Requires Noncardiac Surgery

Presenter: Sunil Rao

September 28, 2019

Presentation TCT 2019

Case 1: A Complex Multivessel PCI in an Elderly Woman

Presenter: James Hermiller

September 28, 2019

Presentation TCT 2019

Approaches to Reduce Bleeding Risk Post PCI in Patients Requiring OAC: Is There Any Role for ASA?

Presenter: C. Michael Gibson

September 28, 2019

Presentation TCT 2019

Role of New-Gen DES in Patients at HBR: Does Stent Type Matter?

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Welcome, Introductions, and Session Goals

Presenter: Roxana Mehran

September 28, 2019

Presentation TCT 2019

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

Presenter: Aditya Kapoor

September 28, 2019

Presentation TCT 2019

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

Presenter: Hirotoshi Watanabe

September 28, 2019

Presentation TCT 2019

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

Presenter: Amit Vora

September 28, 2019

Presentation TCT 2019

Aspirin Variability, Interactions and Impact of Different Formulations

Presenter: Dominick Angiolillo

September 28, 2019

Presentation TCT 2019

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Presenter: Sanjit Jolly

September 28, 2019

Presentation TCT 2019

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Presenter: Davide Capodanno

September 28, 2019

Presentation TCT 2019

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

Presenter: Francesco Franchi

September 27, 2019

Presentation TCT 2019

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

Presenter: Carlo Di Mario

September 27, 2019

Presentation TCT 2019

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Presenter: Yoshinobu Onuma

September 27, 2019

Advertisement

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Case 3: A Patient With AF and ACS

Case 2: A Patient With Complex Disease Who Requires Noncardiac Surgery

Case 1: A Complex Multivessel PCI in an Elderly Woman

Approaches to Reduce Bleeding Risk Post PCI in Patients Requiring OAC: Is There Any Role for ASA?

Role of New-Gen DES in Patients at HBR: Does Stent Type Matter?

Welcome, Introductions, and Session Goals

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

Aspirin Variability, Interactions and Impact of Different Formulations

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content